Kewaunee Scientific Corp Reports Director/Officer Changes & Financials

TL;DR

Kewaunee Scientific (KEQU) filed an 8-K detailing leadership changes and financial updates.

AI Summary

Kewaunee Scientific Corporation filed an 8-K on September 11, 2025, reporting on events as of September 10, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes amendments to articles of incorporation or bylaws, a change in fiscal year, and financial statements and exhibits.

Why It Matters

This 8-K filing signals potential shifts in Kewaunee Scientific's leadership and corporate structure, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with potential amendments to bylaws, can indicate internal shifts that may affect the company's future performance and stability.

Key Players & Entities

• Kewaunee Scientific Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• September 10, 2025 (date) — Date of earliest event reported
• September 11, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Marke

Filing Documents

• kequ-20250910.htm (8-K) — 34KB
• amendedbylaws.htm (EX-3.1) — 31KB
• pr91125.htm (EX-99.1) — 12KB
• amendedbylaws001.jpg (GRAPHIC) — 184KB
• amendedbylaws002.jpg (GRAPHIC) — 248KB
• amendedbylaws003.jpg (GRAPHIC) — 303KB
• amendedbylaws004.jpg (GRAPHIC) — 240KB
• amendedbylaws005.jpg (GRAPHIC) — 259KB
• amendedbylaws006.jpg (GRAPHIC) — 224KB
• amendedbylaws007.jpg (GRAPHIC) — 295KB
• amendedbylaws008.jpg (GRAPHIC) — 218KB
• amendedbylaws009.jpg (GRAPHIC) — 220KB
• logo_stackedxdark.jpg (GRAPHIC) — 280KB
• 0000055529-25-000038.txt ( ) — 3599KB
• kequ-20250910.xsd (EX-101.SCH) — 2KB
• kequ-20250910_lab.xml (EX-101.LAB) — 22KB
• kequ-20250910_pre.xml (EX-101.PRE) — 13KB
• kequ-20250910_htm.xml (XML) — 3KB

02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 10, 2025, the Board of Directors (the "Board") of Kewaunee Scientific Corporation (the "Company") appointed J. Jette Campbell to serve as a member of the Board, effective immediately. Mr. Campbell will hold office as a Class II director, for a term expiring at the Company's annual meeting of stockholders to be held in 2027 and thereafter until his successor has been duly elected and qualified or until his earlier death, removal or resignation. Mr. Campbell is a highly regarded advisor to lenders and business owners in the areas of financial restructuring, business strategy, and crisis management. Mr. Campbell has served as a partner at Carl Marks Advisors since January 2004. Mr. Campbell's engagements at Carl Marks Advisors have spanned a wide range of industries, including distribution, manufacturing, healthcare, education, real estate, and financial services, and Mr. Campbell has worked extensively in the building materials and furniture-manufacturing industries. Prior to joining Carl Marks Advisors, Mr. Campbell served as an executive at several large multinational firms including Griffin LLC, a DuPont agricultural chemical joint venture (CFO and Head of Corporate Development), PepsiCo (CFO, North European Snack Foods Division), and Frito-Lay (VP and Controller). Mr. Campbell is a certified public accountant and began his career in public accounting with Arthur Andersen & Co. in Houston, Texas. During a 17-year span, he was Partner in both Arthur Andersen & Co. and KPMG Peat Marwick. Mr. Campbell earned an undergraduate degree in business from Auburn University and engaged in post-graduate study at Auburn and Harvard Business School. He has an Honorary Doctorate from Paul Quinn College for his leadership of its executive committee. Mr. Campbell will be compensated for his services as a direct

03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Effective September 10, 2025, the Board approved Amended and Restated Bylaws (the "Bylaws"), which reflect an amendment to Section 5.02 to provide that the number of directors constituting the whole Board will be at least five and not more than nine directors, the exact number to be fixed from time to time by resolution of the Board adopted by the directors then in office. The foregoing description of the amendment to the Bylaws is qualified in its entirety by the full text of the Bylaws filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference herein.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Bylaws (as amended September 10, 2025) 99.1 Press Release of Kewaunee Scientific Corporation dated September 11 , 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: September 11, 2025 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR